期刊： CELLULAR ONCOLOGY, 2022; 45 (1)
Objective It has been reported that tumor-associated lymphangiogenesis plays an important role in lymph node metastasis and contributes to the poor su......
期刊： CELLULAR ONCOLOGY, 2022; 45 (6)
Background CXCL11 has been reported to be up-regulated in hepatocellular carcinoma (HCC) tissues and cancer-associated fibroblasts (CAFs), and CAF-sec......
期刊： CELLULAR ONCOLOGY, 2022; 45 (1)
Background Hippocalcin-like 1 (HPCAL1), a neuronal calcium sensor protein family member, has been reported to regulate cancer growth. As yet, however,......
期刊： CELLULAR ONCOLOGY, 2022; 45 (2)
Pancreatic ductal metaplasia (PDM) is the transformation of potentially various types of cells in the pancreas into ductal or ductal-like cells, which......
期刊： CELLULAR ONCOLOGY, 2022; 45 (5)
Purpose We aimed to elucidate the applicability of tumor organoids for inherent drug resistance of primary liver cancer (PLC) and mechanisms of acquir......
期刊： CELLULAR ONCOLOGY, 2022; 45 (2)
Purpose The mechanism underlying cancer heterogeneity and plasticity remains elusive, in spite of the fact that multiple hypotheses have been put forw......
期刊： CELLULAR ONCOLOGY, 2022; 45 (3)
Background Solute carrier family 26 member (SLC26A9) is a Cl- uniporter with very high expression levels in the gastric mucosa. Here, we describe morp......
期刊： CELLULAR ONCOLOGY, 2022; 45 (3)
Purpose GAS41 is a YEATS domain protein that binds to acetylated histone H3 to promote the chromatin deposition of H2A.Z in non-small cell lung cancer......
期刊： CELLULAR ONCOLOGY, 2022; 45 (5)
Background As the most abundant modification in mRNA, the N-6-methyladenosine (m(6)A) RNA modification is involved in the occurrence and development o......
期刊： CELLULAR ONCOLOGY, 2022; 45 (5)
Src homology 2-containing protein tyrosine phosphatase 2 (SHP2) is a non-receptor protein tyrosine phosphatase ubiquitously expressed mainly in the cy......
期刊： CELLULAR ONCOLOGY, 2022; 45 (2)
Background Phosphohistidine phosphatase 1 (PHPT1) is an oncogene that has been reported to participate in multiple tumorigenic processes. As yet, howe......
期刊： CELLULAR ONCOLOGY, 2022; 45 (1)
Background Sparc/osteonectin, cwcv and kazal-like domain proteoglycan 1 (SPOCK1) has been reported to function as an oncogene in a variety of cancer t......
期刊： CELLULAR ONCOLOGY, 2022; 45 (6)
Abnormal CDK4/6-Rb-E2F signal transduction is a common finding in tumors and is a driving factor for the excessive proliferation of various tumor cell......
期刊： CELLULAR ONCOLOGY, 2022; 45 (4)
Purpose Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) are being used for the first-line treatment of metastatic ......
